Will IVF tear the Texas GOP apart?

This year, after more than ten years campaigning, a vital change was made to abortion law. But the fight isn't over. Here's ...

TRUTAKNA is the first and only available therapy that binds both B-cell activating factor (BAFF) and A PRoliferation-Inducing Ligand (APRIL), addressing the immunological drivers at the source of IgA ...

Copyright: © 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. In 2025, the European ...

An Australian study by researchers at Peter Mac has shown that the natural protection against breast cancer offered by ...

A lawsuit filed by Children’s Health Defense, an organization founded by Robert F. Kennedy Jr., claims that vaccines caused ...

‘A Good First Step’ The Christian right is hailing the pair of anti-trans Supreme Court decisions yesterday, seeing the ...

Researchers from Trinity College Dublin have uncovered new evidence that the communities of bacteria living in the uterus may ...

Anti-TNF therapy has the most favorable safety and disease-control profile during pregnancy, with vedolizumab and ustekinumab performing similarly.

The U.S. Food and Drug Administration (FDA) has approved a new therapy regimen for patients with "double-positive" metastatic ...

Explore an integrative framework for recurrent pregnancy loss assessment. Learn how immune, hormonal, thrombophilic, and male factors impact preconception health.